| Identification | More | [Name]
Cefetamet pivoxil hydrochloride | [CAS]
111696-23-2 | [Synonyms]
(+)-(6r,7r)-pivaloyloxymethyl 7-[(2-amino-4-thiazolyl)
CEFETAMET PIVOXIL HCL
CEFETAMET PIVOXIL HYDROCHLORIDE
)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-,(2,2-dimethyl-1-oxopropoxy)methy
7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-,(2,2-dimethyl-1-oxopropoxy)met5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicaci
monohydrochloride,(6r-(6-alpha,7-beta(z)))-leste
ro15-8075
Ceftamet pivoxil hydrochloride
(6R,7R)-7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (2,2-dimethyl-1-oxopropoxy)methyl ester hydrochloride
CEFEPINE | [Molecular Formula]
C20H26ClN5O7S2 | [MDL Number]
MFCD00864931 | [Molecular Weight]
548.03 | [MOL File]
111696-23-2.mol |
| Hazard Information | Back Directory | [Description]
Cefetamet pivoxil hydrochloride, an ester prodrug of cefetamet, is an orally active
cephalosporin introduced for the treatment of community-acquired respiratory and
urinary tract infections. Roche indicated that this drug will possibly be the first
third-generation cephalosporin to be launched in some counrries. It is reportedly useful in penicillin-resistant pneumococci, gonococci and H. influenzae infections, but
ineffective against Staphylococci, P. aeruginosa and some non-fermenters. | [Originator]
Takeda (Japan) | [Definition]
ChEBI: Cefetamet pivoxil hydrochloride is an organic molecular entity. | [Brand name]
Globocef |
|
|